{
    "2020-09-23": [
        [
            {
                "time": "",
                "original_text": "CRO&CDMO投研体系之数据跟踪(系列四)：2020H1回顾与前瞻 疫情背景下中国企业竞争优势凸显",
                "features": {
                    "keywords": [
                        "CRO",
                        "CDMO",
                        "疫情",
                        "竞争优势",
                        "企业"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报：医保目录调整逐步进行 冠状动脉支架首批纳入器械国采",
                "features": {
                    "keywords": [
                        "医药",
                        "医保目录",
                        "冠状动脉支架",
                        "器械国采"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "恒指震荡收涨0.11%报23742.51点，医药股领涨",
                "features": {
                    "keywords": [
                        "恒指",
                        "震荡",
                        "收涨",
                        "医药股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【行情】港股医药股持续走高，复星医药涨超6%，药明生物、药明康德、上海医药等纷纷走高",
                "features": {
                    "keywords": [
                        "港股",
                        "医药股",
                        "复星医药",
                        "药明生物",
                        "药明康德",
                        "上海医药"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【异动股】药明康德(02359-HK)涨3.52%",
                "features": {
                    "keywords": [
                        "药明康德",
                        "异动股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}